Experience

Universal Sequencing Technology

• United States
• Biotechnology
• 1 - 100 Employee

• Director of R&D

  • Apr 2021 - Present

  Universal Sequencing Technology (UST) is a biotech startup that develops disruptive NGS solutions. UST's portfolio includes products for de novo assembly of microbial metagenomes, long haplotype phasing (single-tube linked-read), and single-cell sequencing technology that can process mammalian and microbial cell mixtures. UST's cross-functional and diverse teams include technology developers, cellular/molecular/computational biologists, mechanical and software engineers, manufacturing and application scientists, and sales & marketing experts.



UC San Diego Health

• United States
• Hospitals and Health Care
• 700 & Above Employee

• Faculty (Associate, Senior Group Leader)

  • Jun 2013 - Mar 2021

  My lab took an integrative (multi-omics) approach to understand the regulatory functions of the human genome and how dysfunction can lead to disease. We identified and characterized mechanisms of hormonal dysregulation, cancer progression, neurodevelopment disorders, and heart disease, using ChIP-seq, ATAC-seq, GRO-seq, RNA-seq, ribo-seq, scRNA-seq, scATAC-seq, CRISPR, and publishing in Nature (2021, 2011, 2010), Cell Reports Medicine (2021), Cell Reports (2020), Cell Research (2020), Nature Genetics (2019), J. Mol. Cell. Cardiology (2017), Nature Commun. (2015), Neuron (2013), PLoS Genetics (2013), J. Ovarian Res. (2013), Cell Cycle (2012), JBC (2013), PLoS Genetics (2011), PNAS (2008).

• Faculty (Assistant, Junior Group Leader)

  • Jul 2007 - Jun 2013